Cybin Inc. logo

Cybin Inc.

AMEX:CYBN

Overview | Financials
Company Name Cybin Inc.
Symbol CYBN
Currency USD
Price 0.45
Market Cap 142,032,600
Dividend Yield 0%
52-week-range 0.21 - 0.738
Industry Biotechnology
Sector Healthcare
CEO Mr. Eric So L.L.B., LLB
Website https://www.cybin.com

An error occurred while fetching data.

About Cybin Inc.

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a

Related Stocks

Electromed, Inc. logo

Electromed, Inc.

ELMD

10.5 USD

Asensus Surgical, Inc. logo

Asensus Surgical, Inc.

ASXC

0.236 USD

Palatin Technologies, Inc. logo

Palatin Technologies, Inc.

PTN

1.96 USD

Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc.

ATNM

4.49 USD

Retractable Technologies, Inc. logo

Retractable Technologies, Inc.

RVP

1.08 USD

CEL-SCI Corporation logo

CEL-SCI Corporation

CVM

2.18 USD

Stereotaxis, Inc. logo

Stereotaxis, Inc.

STXS

1.56 USD

VolitionRx Limited logo

VolitionRx Limited

VNRX

0.748 USD

Milestone Scientific Inc. logo

Milestone Scientific Inc.

MLSS

0.804 USD

Financials

Numbers are in millions USD

Numbers are in millions USD